having us, and thank you for all you do on the AJSM editorial board. We really appreciate all your time and effort and dedication to the journal, and I have a lot of great stats to share with you, and a lot of that's because of every single person in this room. So I wanted to start out with a little bit of an industry kind of background. If you were here last year, this slide might look familiar to you, and if you were in the reviewer workshop, Dr. Voides did a great kind of overview of transformative agreements, also known as open access sales deals. Essentially, a transformative agreement is when an institution, or a hospital, or consortia, or even a government group comes together, and they pay for not only their subscription, but a top-up for open access for all of their faculty to publish in our SAGE journals. So you'll notice that more and more in AJSM and Sports Health, and I'm going to show you those numbers on the next slide. You can see here in the little blue dots, those are all of the open access sales deals that we have. So it equals over 700 institutions worldwide. In North America, we have over 300 institutions that are part of this. So if you are a faculty at any of these schools, please make sure that you're putting that as your first affiliation, so that you can get open access for free, paid for through these deals. So for our circulation subscription numbers, we have about 16,300 subscribers year-to-date for 2023. That will continue to grow a little bit throughout the remainder of the year. We're actually still waiting on one of our biggest deals, which will be about a hundred more subscribers, which should come through in August. We grace access through that time, so people that are members of those institutions where the librarians are still negotiating still have access to AJSM. You can see here at the bottom, package read-only, that line is going down, whereas package with open access is increasing. That's that movement that I just talked about on the prior slide, where they're moving into these open access sales deals from straight subscriptions. And what that looks like for AJSM is here. So for this year, 17 of our articles were made free-to-read open access through these open access sales deals. So we're tracking at about 10% of our content is made open access through these transformative agreements. So you can have all the subscribers in the world, but if no one's reading your content, it doesn't matter. Thankfully for AJSM, people are reading our content. You can see here that we had over 1.7 million full text downloads last year for AJSM, which is absolutely fantastic. A phenomenal number of people are seeing our content. And from those subscribers on the prior slide, most of those are institutions. So it's a lot of eyes on our content, not just individuals. Looking at it by month, it kind of follows the Northern Hemisphere school year. So you see a dip throughout the summer months, and then again in December on the holidays when people take time off. Overall, we're looking really strong for 2023. If you see those huge spikes in 2022, that is an anomaly where because AOSSM was switching over to a new member website, we actually put down the paywall for a couple weeks. We didn't promote it, but people found out. And a lot of people were excited to read AJSM content without logging in. So we had a really nice spike right there for those two months, which are a bit falsely inflated. But even with that, 2023, if we take that out, we are tracking ahead of this time last year. Our top downloaded article is what is the failure rate after arthroscopic repair of bucket handle meniscal tears, a systematic review and meta-analysis. Systematic reviews tend to always do pretty well, both the downloads and citations. Any review articles are pretty strong for AJSM. A shout out to our electronic media editorial board. Thank you so much for all that you do for podcasts, for webinars, for the video content. All of it makes a really big impact on the usage. Also helps with our marketing efforts on our side, because those are really easy things that we can push out via social media, emails. And if you do receive those in your inbox, please pass them along to other people that might be interested. We're trying to get our content out to as many people as we can. I briefly wanted to mention that we do have author and reviewer services and resources. It's probably not for people in this room. It's targeted more for early career researchers. But we do have a big piece of this that's around promoting your articles. So if you are newer to social media or want to get involved, some of these resources might be helpful for you, and they're entirely free. So just wanted to mention them in case you do have someone that you're mentoring where this would be helpful. Additionally, with our redesign that went live last September, so you may have noticed that the website looks a little bit different. We did input a new e-reader aspect, as well as a share feature. So if you are logged in, you can share your access and give 90-day free access to any article in AJSM. So if you are on social media, that is a great benefit. So you can share your login essentially without having to share the PDF, without having to give away your username and password. You just click that share link and it generates it for you for 90 days. So I highly recommend that. The e-reader is also new and exciting and helps with our advertising efforts as well. This basically marries the functionality of the PDF that we all know and love with everything that you can do in HTML. So you can put notes on it, you can highlight. It's a really good new service that's been growing in our usage. So I do recommend you check it out as well. I wanted to look at the impact beyond just downloads and citations for AJSM. So this shows you the altmetrics, which is the online conversation around content. So I know that that's something that AJSM has looked at over the years. We had an editorial, I think, talked to a writer back in like 2016 about altmetrics when this was new. But it's always something fun to track and I know because of how involved you all are with the electronic media, with social media, it is something that we like to look at for the journal. So we've had over a hundred and ten thousand mentions online, not including any citations in academic journals. So this is entirely because of social media, over a hundred and two thousand, because of news and blog posts, as well as policy and patent documents. So just seeing the impact that we're having beyond even the expected impact of downloads and citations is really exciting to see and shows how far our work is going. So I've mentioned this last couple years. There have been ongoing changes to the impact factor year over year. This year kind of ends the big change period, at least to our knowledge from Clarivate Analytics, who owns the impact factor. You'll notice that your impact factors went down to one decimal point instead of the three decimal points. We also had 9,000 new journals added to the impact factor this year. So with adding on the Emerging Sources Citation Index and the Arts and Humanities Index, that's a lot of new journals that have impact factors for the first time. Additionally, it has moved entirely to the electronic publication date instead of the issue publication date, which it was a few years ago. And as a reminder, it's citations in the current year of the impact factor, so for us 2022, to the prior two years of content over the prior two years of content citable items. And I will show you kind of what that looks like coming up. So for AJSM, we did see a dip. We did expect to see that. We moved to a 4.8 for our two-year impact factor, but in that we had over 4,300 citations, so our citations are still very impressive. And the reason for this is really our citable items went up. So during COVID, when everyone was at home, a lot of people were submitting content, and a lot of it was quality content coming to AJSM. So we published 905 citable items during that two-year period, which is a great problem to have. So huge increase there, but pre-COVID levels of citations. Our top cited article is actually on par with last year's top cited article. It's actually the same article. The lateral extra articular tenogenesis reduces failure of hamstring tendon autograft, ACL reconstruction. So that actually had 80 citations. And I'll show you on this slide, kind of so you can get a feel for how this looked for the other orthopedic journals that are still in our category, so you can see kind of where we fall. We have basically a large percentage more of citable content in our denominator compared to a lot of our competitors, and quite a bit more citations. But because our denominator went up so much, and in 2022, across the industry there just wasn't as many articles published, there were less chances for citations. So just wanted to kind of give you a little bit of context to the numbers here, because our citations are truly something to continue to be proud of, and I think AJSM is a fantastic journal. You can also see here for some of the competitors, a lot of them published COVID articles, clinical practice guidelines, and new scales, which always tend to be articles that get heavily cited. Anytime you have a clinical practice guideline or a new evidence scale, those get cited continuously. So they will continue to do well within their two year period. Giving context beyond the two year impact factor, AJSM does extremely well when you look at longer periods of kind of the year lengths. So in 2022, to all AJSM content, we had almost 42,000 total citations in one year to everything that we have ever published. And those are just citations from Web of Science, which only looks at journals with impact factors. So very impressive, and kudos to all of you. Our cite score is an incredible 4.5, and our citations are our cite score is an incredible 9.8 for 2022. And our five year impact factors over six. So overall, definitely things to still be proud of. And because AJSM has taken so seriously the diversity, equity inclusion, you have your fantastic task force, and your pledge document that you shared last year, I just wanted to share some of the initiatives that we're doing at SAGE so we can continue to partner with you in this way. So I already talked about our pledge last year, and the year before, but just as a reminder, we want to publish resources and content that represent diverse populations and perspectives, and that actively acknowledge injustices. So we find that very important. We want to enable content that reduces barriers for marginalized population groups. We want to increase representation across the publishing industry. And we also want to enhance the technology, usability, and the design of our resources. So a lot around accessibility as well, because that's something that we can actively do on the technology side. So how that plays out, we have these microsites, which I do publish and promote content from AJSM in whenever they're relevant. And if you haven't looked at them, I do highly recommend it. We do a lot of marketing around this as well. And using these thematic ways, we can actually take AJSM content and put it to people that otherwise may not have seen it, and they can interact with the content in new and different ways. So we'll continue to do that. I will let you know as new microsites come out, but I just wanted to mention those resources. And I will pass this around afterwards, but this is something that we truly believe in, and I know you do too. So we'd love to continue to partner with you in this way. So thank you. Any questions I can answer?

AJSM

American Journal of Sports Medicine

transformative agreements

circulation subscription numbers

open access